Project Grant 2304250
Award Date 9/1/23
Completion Date 8/31/24
Dollars Obligated $271K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Raleigh, NC 27607, USA
Similar Awards
- Federal Cooperative Agreement Summary Novozymes, Inc. received a $2.14 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) awarded August 1, 2025, with completion targeted for July 31, 2028. The project focuses on developing bio-based production capabilities for human milk oligosaccharides (HMOs)—complex sugars that provide essential nutritional and developmental benefits in breast milk. The award supports the...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) award provides $274,727 to Weka Biosciences LLC, a woman-owned small business, to develop a novel microbial process for creating a synthetic sugar polymer for use in chiral chromatography. The goal is to produce a more reliable and efficient polymer material to enhance the precision of drug manufacturing and contribute to safer, more effective medications. The 12-month project will focus on...
- This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $274,946 to Free To Feed, Inc. to develop a real-time, at-home allergen detection test for human milk. The goal is to provide a rapid and cost-effective solution to determine the allergen content of human milk, addressing the issue that up to 25% of infants have reported allergic responses to proteins found in breast milk, which can lead to...
- This Cooperative Agreement from the National Science Foundation will support Sasya Inc.'s research and development of sustainable production methods for high-performance dietary supplements through July 2024. Funded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the $995,239 award aims to facilitate improved animal husbandry practices by providing natural supplements that can replace prophylactic antibiotics, drugs, and hormones in animal feed. The recipient will...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,918 to Cascade Biocatalysts Inc. will fund research and development to demonstrate the commercial feasibility and scalability of a patent-pending approach for stabilizing enzymes through engineered polymer-enzyme interactions. The goal is to enable environmentally sustainable, low-carbon chemical manufacturing processes that utilize enzymes as catalysts, which can decrease...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Om Therapeutics Inc. will support the development of a system to enable the rapid, scalable, and cost-effective discovery of new medicines using machine learning. The project aims to encapsulate proteins and small molecules in millions of miniaturized compartments to screen for interactions that could identify novel drug candidates. The key innovations include...
- This National Science Foundation (NSF) Cooperative Agreement award for $998,064 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a new testing standard and benchmarking platform to measure the biological effects of functional ingredients used in dietary supplements, foods, beverages, and skincare products. The project, led by Canomiks, Inc., will use genomics and artificial intelligence technologies to create high-throughput, cost-effective...
- This National Science Foundation Project Grant of $750,000 will fund the development of dairy protein product innovations through the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). Awarded on December 15, 2022 to Boise State University, the project aims to modernize dairy processing using artificial intelligence, advanced sensing and manufacturing technologies. Key deliverables include creating AI-based solutions to automate real-time protein analysis in milk processing...
- Cooperative Agreement Summary: Synthetic Mucin Biomaterials Development Nomi Materials Corp received a $1.23M Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective October 1, 2025, through September 30, 2027. Under this Small Business Innovation Research (SBIR) Phase II project, the awardee will develop and commercialize scalable synthetic mucin biomaterials—engineered glycosylated polypeptides that replicate the...
- The National Science Foundation (NSF) has awarded a $2,233,515 Cooperative Agreement to Arzeda Corp under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to transform the production of acrylates, which are high-value chemical components used in products like paints and plastics, by leveraging artificial intelligence (AI)-driven biotechnology. The team will engineer enzymes to utilize non-natural cofactors, enabling a scalable, cost-effective, and...